Literature DB >> 34166554

Notch-Hes1 signaling activation in Caroli disease and polycystic liver disease.

Kenta Takahashi1, Yasunori Sato1, Minako Yamamura1, Satoko Nakada2, Yuko Tamano1, Motoko Sasaki1, Kenichi Harada1.   

Abstract

The Notch signaling pathway plays a key role in the morphogenesis of the biliary tree, but its involvement in cystic biliary diseases, such as Caroli disease (CD) and polycystic liver disease (PLD), has yet to be determined. Immunostaining was performed using liver sections of CD and PLD, and the results were compared with those of congenital hepatic fibrosis (CHF) and von Meyenburg complex (VMC). The expression of Notch receptor 1 (Notch1) was increased in the nuclei of biliary epithelial cells in all cases of CD and PLD, whereas it remained at a low level in CHF and VMC. In addition, Notch2 and Notch3 were preferably expressed in the nuclei of biliary epithelial cells of PLD. Accordingly, the Notch effector Hes1 was highly expressed in biliary epithelial cells of CD and PLD, and the cell proliferative activity was significantly higher in CD and PLD. The expression of the Notch ligand Delta-like 1 was significantly increased in biliary epithelial cells of CD and PLD, which may be causally associated with the nuclear overexpression of Notch1 and Hes1. These results indicate that aberrant activation of the Notch-Hes1 signaling pathway may be responsible for the progression of biliary cystogenesis in CD and PLD.
© 2021 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Caroli disease; Hes1; Notch; congenital hepatic fibrosis; polycystic liver disease; therapeutic target; von Meyenburg complex

Mesh:

Substances:

Year:  2021        PMID: 34166554     DOI: 10.1111/pin.13130

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

Review 1.  Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics.

Authors:  Yongqin Ye; Vincent Chi Hang Lui; Paul Kwong Hang Tam
Journal:  Genes (Basel)       Date:  2022-06-08       Impact factor: 4.141

2.  Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism.

Authors:  Dino Šisl; Darja Flegar; Maša Filipović; Petra Turčić; Pavao Planinić; Alan Šućur; Nataša Kovačić; Danka Grčević; Tomislav Kelava
Journal:  Biomedicines       Date:  2022-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.